Cronos Group Reports 2023 Second Quarter Results
08 août 2023 07h30 HE
|
Cronos Group Inc.
Industry-leading balance sheet with $841 million in cash and short-term investments Increased 2023 operating expense savings target to $20 to $25 million Announces additional initiatives to...
Cronos Group Inc. to Hold 2023 Second Quarter Earnings Conference Call on August 8, 2023
20 juil. 2023 09h00 HE
|
Cronos Group Inc.
TORONTO, July 20, 2023 (GLOBE NEWSWIRE) -- Cronos Group Inc. (NASDAQ: CRON) (TSX: CRON) (“Cronos” or the “Company”) will hold its 2023 second quarter earnings conference call on Tuesday, August 8,...
Cronos Group Inc. confirms receipt of unsolicited indications of interest
06 juil. 2023 17h28 HE
|
Cronos Group Inc.
TORONTO, July 06, 2023 (GLOBE NEWSWIRE) -- Cronos Group Inc. (NASDAQ: CRON) (TSX: CRON) (“Cronos” or the “Company”) today confirmed that it has received a number of unsolicited indications of...
Cronos Group Inc. Announces Results of 2023 Annual Meeting of Shareholders
23 juin 2023 16h15 HE
|
Cronos Group Inc.
TORONTO, June 23, 2023 (GLOBE NEWSWIRE) -- Cronos Group Inc. (NASDAQ: CRON) (TSX: CRON) (“Cronos” or the “Company”) announces that at its Annual Meeting of Shareholders held yesterday, June 22, 2023...
Cronos Group Announces Streamlined Operating Structure to Improve Cash Flow
31 mai 2023 16h50 HE
|
Cronos Group Inc.
Plans to Exit Existing U.S. hemp-derived CBD Operations Intends to Launch Lord Jones® Brand in the Canadian Adult-use Market in Q4 2023 TORONTO, May 31, 2023 (GLOBE NEWSWIRE) -- Cronos Group Inc....
Cronos Group Inc. to Speak at Bernstein's 39th Annual Strategic Decisions Conference
30 mai 2023 13h00 HE
|
Cronos Group Inc.
TORONTO, May 30, 2023 (GLOBE NEWSWIRE) -- Cronos Group Inc. (NASDAQ: CRON) (TSX: CRON) (“Cronos” or the “Company”), an innovative global cannabinoid company, today announced that Mike Gorenstein,...
Cronos Group Inc. to Speak at the Canaccord Genuity 7th Annual Global Cannabis Conference
12 mai 2023 15h00 HE
|
Cronos Group Inc.
TORONTO, May 12, 2023 (GLOBE NEWSWIRE) -- Cronos Group Inc. (NASDAQ: CRON) (TSX: CRON) (“Cronos” or the “Company”), an innovative global cannabinoid company, today announced that Mike Gorenstein,...
Cronos Group Reports 2023 First Quarter Results
09 mai 2023 07h30 HE
|
Cronos Group Inc.
Industry-leading balance sheet with $836 million in cash and short-term investments Targeting positive cash flow in 2024 Net revenue in Canada increased 6% in Q1 2023 compared to Q1 2022; on a...
Cronos Group Inc. to Hold Virtual 2023 Annual Meeting of Shareholders
28 avr. 2023 17h00 HE
|
Cronos Group Inc.
TORONTO, April 28, 2023 (GLOBE NEWSWIRE) -- Cronos Group Inc. (NASDAQ: CRON) (TSX: CRON) (“Cronos” or the “Company”) will hold its 2023 Annual Meeting of Shareholders on Thursday, June 22, 2023, at...
Cronos Group Inc. to Hold 2023 First Quarter Earnings Conference Call on May 9, 2023
25 avr. 2023 16h15 HE
|
Cronos Group Inc.
TORONTO, April 25, 2023 (GLOBE NEWSWIRE) -- Cronos Group Inc. (NASDAQ: CRON) (TSX: CRON) (“Cronos” or the “Company”) will hold its 2023 first quarter earnings conference call on Tuesday, May 9, 2023...